Evista (chemical name: raloxifene) is a SERM approved by the U.S. Food and Drug Administration (FDA) to: 1  reduce the risk of hormone-receptor-positive breast cancer in postmenopausal women who haven't been diagnosed but are at higher-than-average risk for disease.
Types of paper ICT Express publishes original research papers in English in the fields of ICT convergence, platform technologies, communication networks, and device technologies. ICT Express accepts short-length (up to 4 pages in double columns and additional 2 pages will be allowed with over page charge (100USD/1page)) high-quality, original articles in Latex or Word format. Sample manuscript can be downloaded here.
By clicking the submit button, you are giving Intuit permission to provide this information to a QuickBooks Enterprise consultant.This consultant may be an Intuit sales representative or an Intuit Premier Reseller in your area. Intuit respects and protects your privacy.y clicking the submit button, you are giving Intuit permission to provide this information to a QuickBooks Enterprise consultant.